Previous issues

  • HOME
  • BROWSE ARTICLES
  • Previous issue
Volume 25(3); Sep 2019
Reviews
1442
Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
Yeun-Yoon Kim, Mi-Suk Park, Khalid Suliman Aljoqiman, Jin-Young Choi, Myeong-Jin Kim
Clin Mol Hepatol. 2019;25(3):223-233.   Published online January 21, 2019
1448
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
Tae-Hyung Kim, So Yeon Kim, An Tang, Jeong Min Lee
Clin Mol Hepatol. 2019;25(3):245-263.   Published online February 14, 2019
Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal
Clin Mol Hepatol. 2019;25(3):264-269.   Published online March 4, 2019
1459
Sarcopenia: Ammonia metabolism and hepatic encephalopathy
Ankur Jindal, Rakesh Kumar Jagdish
Clin Mol Hepatol. 2019;25(3):270-279.   Published online April 22, 2019
Editorial
How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
Jung Hwan Yu, Jin-Woo Lee
Clin Mol Hepatol. 2019;25(3):280-282.   Published online January 21, 2019
Original Articles
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Clin Mol Hepatol. 2019;25(3):283-293.   Published online November 13, 2018
Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes
Ebrahim Banitalebi, Mohammad Faramarzi, Samira Nasiri, Majid Mardaniyan, Vahid Rabiee
Clin Mol Hepatol. 2019;25(3):294-304.   Published online May 30, 2019
Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
Linda Wong, Kliment Bozhilov, Brenda Hernandez, Sandi Kwee, Owen Chan, Luke Ellis, Loic LeMarchand
Clin Mol Hepatol. 2019;25(3):305-316.   Published online April 19, 2019
Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?
Elham Ahmed Hassan, Abeer Sharaf El-Din Abdel Rehim, Mohamed Omar Abdel-Malek, Asmaa Omar Ahmed, Nourhan Mahmoud Abbas
Clin Mol Hepatol. 2019;25(3):317-325.   Published online June 10, 2019
Letters to the editor
Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report
Rahul Kumar, John Chen Hsiang, Jessica Tan, Prem Harichander Thurairajah
Clin Mol Hepatol. 2019;25(3):326-330.   Published online December 4, 2018
Letters to the Editor
Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
Dimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, Michael Doumas
Clin Mol Hepatol. 2019;25(3):331-332.   Published online May 30, 2019

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 214
TOTAL : 617887
Close layer